POXEL FRANCE PE Ratio 2019-2021 | PXXLF
Current and historical p/e ratio for POXEL FRANCE (PXXLF) from 2019 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. POXEL FRANCE PE ratio as of October 22, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|POXEL FRANCE PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
Poxel SA is a biopharmaceutical company. It offers drugs for metabolic diseases such as diabetes and related metabolic disorders. The company's product pipeline consists of Imeglimin, PXL770 and PXL007 which are in clinical trial stage. Poxel SA is headquartered in Lyon, France.